COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2018

Jul 12, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2018-07-10

Reporting Person: Dreyer Scott (EVP & Chief Commercial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Purchase)	$24.03	2028-04-04	Common Stock (75000)		Direct

Footnotes

F1: Twenty-five percent (25%) of the option vests and becomes exercisable on January 2, 2019, and the balance vests in equal monthly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer.